Groundbreaking HIV study launches

Dr Makhema
Dr Makhema

The Botswana Harvard AIDS Institute Partnership (BHP) yesterday launched its inaugural clinical study to look into the effectiveness of antibodies in reducing the acquisition of HIV among high-risk female populations.The research explores a new idea for HIV prevention, investigators explained on Tuesday.

The study, which started in July, targets a maximum of 300 women aged between 18-40 among whom the HIV incidence is leading in sub-Saharan Africa, in addition to glaring disproportions among their male counterparts.

For instance, HIV incidence among 15 to 19-year-olds is reported to be three percent for males, and much more for females at seven percent.

Editor's Comment
Tighten the law on drug dealers

Our youth are perishing; their once hopeful bright future is going down the drain; all because of illicit drugs.It is very easy to blame the addict, but it is not as simple as that! Drug dealing is a very lucrative business for some shameless people amongst our society and as such they have come up with tight strategies on how to push their business.Drug addiction is bad, and while the individual on drugs sometimes might have been the one who...

Have a Story? Send Us a tip
arrow up